skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 204  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date
Material Type:
Article
Add to My Research

Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date

Drug design, development and therapy, 2018-01, Vol.12, p.2539-2552 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 King et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S150043 ;PMID: 30147301

Full text available

2
Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative Review
Material Type:
Article
Add to My Research

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative Review

Clinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.1019-1045 [Peer Reviewed Journal]

2022 Kishore et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Kishore et al. 2022 Kishore et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S209395 ;PMID: 35418744

Full text available

3
Effectiveness of the Use of Three-Dose Intravitreal Ziv-Aflibercept in the Management of Diabetic Macular Edema in a Real-Life Setting
Material Type:
Article
Add to My Research

Effectiveness of the Use of Three-Dose Intravitreal Ziv-Aflibercept in the Management of Diabetic Macular Edema in a Real-Life Setting

Clinical ophthalmology (Auckland, N.Z.), 2023-01, Vol.17, p.1129-1135 [Peer Reviewed Journal]

2023 Munayco-Guillén et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Munayco-Guillén et al. 2023 Munayco-Guillén et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S398359 ;PMID: 37077223

Full text available

4
Prognosis of Ischemic Stroke Patients Undergoing Endovascular Thrombectomy is Influenced by Systemic Inflammatory Index Through Malignant Brain Edema
Material Type:
Article
Add to My Research

Prognosis of Ischemic Stroke Patients Undergoing Endovascular Thrombectomy is Influenced by Systemic Inflammatory Index Through Malignant Brain Edema

Clinical interventions in aging, 2022-01, Vol.17, p.1001-1012 [Peer Reviewed Journal]

COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Ji et al. 2022 Ji et al. ;ISSN: 1178-1998 ;ISSN: 1176-9092 ;EISSN: 1178-1998 ;DOI: 10.2147/CIA.S365553 ;PMID: 35814350

Full text available

5
Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor
Material Type:
Article
Add to My Research

Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.661-669 [Peer Reviewed Journal]

2021 Elfalah et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Elfalah et al. 2021 Elfalah et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S289068 ;PMID: 33628009

Full text available

6
The efficacy and safety of aflibercept and conbercept in diabetic macular edema
Material Type:
Article
Add to My Research

The efficacy and safety of aflibercept and conbercept in diabetic macular edema

Drug design, development and therapy, 2018-01, Vol.12, p.3471-3483 [Peer Reviewed Journal]

2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Cai et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S177192 ;PMID: 30410308

Full text available

7
Faricimab for Treatment-Resistant Diabetic Macular Edema
Material Type:
Article
Add to My Research

Faricimab for Treatment-Resistant Diabetic Macular Edema

Clinical ophthalmology (Auckland, N.Z.), 2022-08, Vol.16, p.2797-2801 [Peer Reviewed Journal]

COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Rush and Rush. 2022 Rush and Rush. ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S381503 ;PMID: 36042912

Full text available

8
The Effect of Anti-Vascular Endothelial Growth Factor on Retinal Microvascular Changes in Diabetic Macular Edema Using Swept-Source Optical Coherence Tomography Angiography
Material Type:
Article
Add to My Research

The Effect of Anti-Vascular Endothelial Growth Factor on Retinal Microvascular Changes in Diabetic Macular Edema Using Swept-Source Optical Coherence Tomography Angiography

Clinical ophthalmology (Auckland, N.Z.), 2020-01, Vol.14, p.3871-3880 [Peer Reviewed Journal]

2020 Pongsachareonnont et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Pongsachareonnont et al. 2020 Pongsachareonnont et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/opth.s270410 ;PMID: 33235428

Full text available

9
Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular Edema
Material Type:
Article
Add to My Research

Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular Edema

Clinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.733-746 [Peer Reviewed Journal]

2022 Zakaria et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Zakaria et al. 2022 Zakaria et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S351853 ;PMID: 35300032

Full text available

10
Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
Material Type:
Article
Add to My Research

Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema

Clinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.603-609 [Peer Reviewed Journal]

2022 Tran et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;Distributed under a Creative Commons Attribution 4.0 International License ;2022 Tran et al. 2022 Tran et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S352152 ;PMID: 35310546

Full text available

11
Optical Coherence Tomography Angiography Biomarkers Predict Anatomical Response to Bevacizumab in Diabetic Macular Edema
Material Type:
Article
Add to My Research

Optical Coherence Tomography Angiography Biomarkers Predict Anatomical Response to Bevacizumab in Diabetic Macular Edema

Diabetes, metabolic syndrome and obesity, 2022-01, Vol.15, p.395-405 [Peer Reviewed Journal]

2022 Elnahry et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Elnahry et al. 2022 Elnahry et al. ;ISSN: 1178-7007 ;EISSN: 1178-7007 ;DOI: 10.2147/DMSO.S351618 ;PMID: 35177916

Full text available

12
Changes of Optical Coherence Tomography Biomarkers in Macular Edema Secondary to Retinal Vein Occlusion After Anti-VEGF and Anti-Inflammatory Therapies
Material Type:
Article
Add to My Research

Changes of Optical Coherence Tomography Biomarkers in Macular Edema Secondary to Retinal Vein Occlusion After Anti-VEGF and Anti-Inflammatory Therapies

Drug design, development and therapy, 2022-03, Vol.16, p.717-725 [Peer Reviewed Journal]

2022 Ding et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Ding et al. 2022 Ding et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S351683 ;PMID: 35313554

Full text available

13
Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options
Material Type:
Article
Add to My Research

Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.375-385 [Peer Reviewed Journal]

2021 Veritti et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Veritti et al. 2021 Veritti et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S236423 ;PMID: 33551641

Full text available

14
Theaflavin alleviates inflammatory response and brain injury induced by cerebral hemorrhage via inhibiting the nuclear transcription factor kappa β-related pathway in rats
Material Type:
Article
Add to My Research

Theaflavin alleviates inflammatory response and brain injury induced by cerebral hemorrhage via inhibiting the nuclear transcription factor kappa β-related pathway in rats

Drug design, development and therapy, 2018-01, Vol.12, p.1609-1619 [Peer Reviewed Journal]

2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Fu et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S164324 ;PMID: 29928110

Full text available

15
Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials
Material Type:
Article
Add to My Research

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials

Clinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10 (Issue 1), p.1103-1110 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Dugel et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S100764 ;PMID: 27366049

Full text available

16
Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
Material Type:
Article
Add to My Research

Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema

Clinical interventions in aging, 2013-01, Vol.8, p.467-483 [Peer Reviewed Journal]

COPYRIGHT 2013 Dove Medical Press Limited ;COPYRIGHT 2013 Dove Medical Press Limited ;2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Fong and Lai, publisher and licensee Dove Medical Press Ltd 2013 ;ISSN: 1178-1998 ;ISSN: 1176-9092 ;EISSN: 1178-1998 ;DOI: 10.2147/CIA.S36811 ;PMID: 23766636

Full text available

17
Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
Material Type:
Article
Add to My Research

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.253-260 [Peer Reviewed Journal]

2021 Pessoa et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Pessoa et al. 2021 Pessoa et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S280644 ;PMID: 33519187

Full text available

18
Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema in Eyes with Branch Retinal Vein Occlusion with vs Without Glaucoma – Does Glaucoma Affect Visual Outcome in Eyes with BRVO-ME After antiVEGF Injections?
Material Type:
Article
Add to My Research

Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema in Eyes with Branch Retinal Vein Occlusion with vs Without Glaucoma – Does Glaucoma Affect Visual Outcome in Eyes with BRVO-ME After antiVEGF Injections?

Clinical ophthalmology (Auckland, N.Z.), 2022-07, Vol.16, p.2275-2283 [Peer Reviewed Journal]

COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Asami et al. 2022 Asami et al. ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S356727 ;PMID: 35872969

Full text available

19
Photobiomodulation Therapy for Age-Related Macular Degeneration and Diabetic Retinopathy: A Review
Material Type:
Article
Add to My Research

Photobiomodulation Therapy for Age-Related Macular Degeneration and Diabetic Retinopathy: A Review

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.3709-3720 [Peer Reviewed Journal]

2021 Muste et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Muste et al. 2021 Muste et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S272327 ;PMID: 34511875

Full text available

20
Vitrectomy for center-involved diabetic macular edema
Material Type:
Article
Add to My Research

Vitrectomy for center-involved diabetic macular edema

Clinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10 (Issue 1), p.735-742 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Browning et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/opth.s104906 ;PMID: 27175056

Full text available

Results 1 - 20 of 204  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2013  (3)
  2. 2013 To 2014  (4)
  3. 2015 To 2016  (16)
  4. 2017 To 2019  (58)
  5. After 2019  (124)
  6. More options open sub menu

Language 

  1. Japanese  (7)
  2. Norwegian  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait